Literature DB >> 11142647

Conditioned increases in behavioral activity and accumbens dopamine levels produced by intravenous cocaine.

C L Duvauchelle1, A Ikegami, E Castaneda.   

Abstract

In vivo microdialysis, behavioral activity assessments, and a conditioned place preference (CPP) test were used to investigate dopaminergic correlates of cocaine-conditioned behaviors. Over 12 days, rats were given either intravenous cocaine (4.2 mg/kg) or saline (6 cocaine and 6 saline infusions) daily in distinctively different environments. The following day, rats were tested in the cocaine- and saline-paired environments; 48 hr later, CPP was determined. The cocaine-associated environment elicited greater nucleus accumbens dopamine (NAcc DA) levels, hyperactivity, and place preference, though the emergence of DA increases was not in synchrony with peak behavioral activation. Although conditioned behavioral effects after repeated cocaine are well documented, direct evidence of increased NAcc DA in response to a cocaine-paired environment has not been previously reported. Discrepancies with previous work are attributed to a number of methodological differences.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11142647     DOI: 10.1037//0735-7044.114.6.1156

Source DB:  PubMed          Journal:  Behav Neurosci        ISSN: 0735-7044            Impact factor:   1.912


  26 in total

1.  Adolescent social defeat increases adult amphetamine conditioned place preference and alters D2 dopamine receptor expression.

Authors:  A R Burke; M J Watt; G L Forster
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

Review 2.  Microdialysis and the neurochemistry of addiction.

Authors:  Mary M Torregrossa; Peter W Kalivas
Journal:  Pharmacol Biochem Behav       Date:  2007-09-12       Impact factor: 3.533

Review 3.  Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.

Authors:  Marco Leyton; Paul Vezina
Journal:  Trends Pharmacol Sci       Date:  2014-04-30       Impact factor: 14.819

4.  Augmentation of Heroin Seeking Following Chronic Food Restriction in the Rat: Differential Role for Dopamine Transmission in the Nucleus Accumbens Shell and Core.

Authors:  Tracey M D'Cunha; Emilie Daoud; Damaris Rizzo; Audrey B Bishop; Melissa Russo; Gabrielle Mourra; Laurie Hamel; Firas Sedki; Uri Shalev
Journal:  Neuropsychopharmacology       Date:  2016-11-08       Impact factor: 7.853

5.  Understanding Addiction Using Animal Models.

Authors:  Brittany N Kuhn; Peter W Kalivas; Ana-Clara Bobadilla
Journal:  Front Behav Neurosci       Date:  2019-11-29       Impact factor: 3.558

6.  Differential impact of pavlovian drug conditioned stimuli on in vivo dopamine transmission in the rat accumbens shell and core and in the prefrontal cortex.

Authors:  Valentina Bassareo; Maria Antonietta De Luca; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-10-28       Impact factor: 4.530

7.  Diazepam alters cocaine self-administration, but not cocaine-stimulated locomotion or nucleus accumbens dopamine.

Authors:  Esther Y Maier; Ramon T Ledesma; Andrew P Seiwell; Christine L Duvauchelle
Journal:  Pharmacol Biochem Behav       Date:  2008-07-20       Impact factor: 3.533

Review 8.  Striatal ups and downs: their roles in vulnerability to addictions in humans.

Authors:  Marco Leyton; Paul Vezina
Journal:  Neurosci Biobehav Rev       Date:  2013-01-16       Impact factor: 8.989

9.  DAT genotype modulates brain and behavioral responses elicited by cigarette cues.

Authors:  Teresa R Franklin; Falk W Lohoff; Ze Wang; Nathan Sciortino; Derek Harper; Yin Li; Will Jens; Jeffrey Cruz; Kyle Kampman; Ron Ehrman; Wade Berrettini; John A Detre; Charles P O'Brien; Anna Rose Childress
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

10.  Dopamine increases in striatum do not elicit craving in cocaine abusers unless they are coupled with cocaine cues.

Authors:  Nora D Volkow; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Jean Logan; Anna-Rose Childress; Millard Jayne; Yeming Ma; Christopher Wong
Journal:  Neuroimage       Date:  2007-10-11       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.